abstract |
The invention concerns compounds of Formula (I): nor pharmaceutically acceptable salts thereof, wherein R 1 n, R 2 n, X, Ring A, Ring B and Ring C have any of the meanings hereinbefore defined in the description; process for their preparation; pharmaceutical compositions containing them and their use in treating MCT4 mediated diseases. |